6BG Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lytix Biopharma AS

Watchlist Manager

Watchlist

Price: 0.756 EUR -2.07% Market Closed

Market Cap: €460.1k

L	Lytix Biopharma AS F:6BG	NO
B	Brunswick Corp XMUN:BWI	US
	F5 Inc NASDAQ:FFIV	US
P	PPL Corp DUS:PP9	US
	BASF SE XETRA:BAS	DE
D	Deutsche Boerse AG F:DB1	DE
	Man Wah Holdings Ltd F:AAM	HK
	Bravura Solutions Ltd ASX:BVS	AU
S	SBM Offshore NV XHAM:IHCB	NL
	MS&AD Insurance Group Holdings Inc OTC:MSADY	JP
	Granges AB F:9GR	SE
A	Ad Pepper Media International NV XMUN:APM	DE
S	Sanmina Corp XMUN:SAYN	US

Profitability Summary

Lytix Biopharma AS's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-6.108%

Low Net Margin

Negative 3Y Average Net Margin

-5.934%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-4.751%

Negative ROE

-70%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-3.607%

ROIC is Increasing

-3.698% > -1.474%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.